Recall Z-0276-2022 ยท GJS Test, Time, Prothrombin
Instrumentation Laboratory
HemosIL ReadiPlasTin (20 mL), Part number 0020301400. An in vitro diagnostic thromboplastin reagent.
| Date | Nov 23, 2021 (initiated Oct 13, 2021) |
| Status | Open, Classified |
| Reason | The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or do not pass for each vial of reagent, there is a potential risk of reporting an erroneous result. |
| Root cause | Under Investigation by firm |
| Action | On October 13, 2021, the firm sent customers Urgent Medical Device Removal letters via email. These emails were followed by certified letters sent starting the same day. ***On February 17, 2022, the firm expanded the recall to include an additional lot of product.*** The customers were provided with instructions to run quality controls with each vial. Customers should discard any vials with failed quality controls. For technical questions, please contact the IL Technical Support Center at 1-800-678-0710, Option # 2 (ACL Coagulation Products). For alternate lot availability questions, pleas |
| Quantity | 5828 kits (310 US) |
| Distribution | Worldwide distribution - US Nationwide distribution in the states of AZ, CA, IA, IL, KS, ME, MI, NC, NY, OK, SC, and VA. The countries of Canada, Chile, China, Costa Rica, Italy, Japan, and South Korea. ***Updated 3/3/22*** Expansion includes states of IN, MN, and NC. |
| FDA record | Open on fda.gov |
510(k) clearances named in this recall
| K122584 | HEMOSIL READIPLAS TIN Instrumentation Laboratory CO, Mar 24, 2013 |